CLINICAL STAGING T2B-3 N0-1 M0

Clinical trials for CLINICAL STAGING T2B-3 N0-1 M0 explained in plain language.

Never miss a new study

Get alerted when new CLINICAL STAGING T2B-3 N0-1 M0 trials appear

Sign up with your email to follow new studies for CLINICAL STAGING T2B-3 N0-1 M0, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

Radiation and immunotherapy combo before lung cancer surgery shows promise in early trial

Disease control Terminated

This phase 2 trial tests whether a low dose of radiation (12 Gy in 3 fractions) combined with one dose of the immunotherapy drug durvalumab can boost the immune system's attack on lung cancer cells before surgery. The study enrolls people with stage 2 or 3 non-small cell lung can…

Matched conditions: CLINICAL STAGING T2B-3 N0-1 M0

Phase: PHASE2 • Sponsor: University Health Network, Toronto • Aim: Disease control

Last updated Jul 01, 2026 00:00 UTC

CLINICAL STAGING T2B-3 N0-1 M0

Get alerted when new CLINICAL STAGING T2B-3 N0-1 M0 trials appear

Radiation and immunotherapy combo before lung cancer surgery shows promise in early trial